カテゴリ： Market Monitor Global, 世界, 医療/バイオ

非麻酔性鎮痛薬のグローバル市場展望 2023年-2029年：サリチル酸塩、アニリン、ピラゾロン、その他有機酸

■ 英語タイトル：Nonnarcotic Analgesics Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23JU5812）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23JU5812
■ 発行日：2023年6月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆医療
■ ページ数：126
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[非麻酔性鎮痛薬のグローバル市場展望 2023年-2029年：サリチル酸塩、アニリン、ピラゾロン、その他有機酸]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の非麻酔性鎮痛薬市場規模と予測を収録しています。・世界の非麻酔性鎮痛薬市場：売上、2018年-2023年、2024年-2029年
・世界の非麻酔性鎮痛薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の非麻酔性鎮痛薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「サリチル酸塩」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

非麻酔性鎮痛薬のグローバル主要企業は、GlaxoSmithKline Consumer Healthcare、 Bayer Corporation、 Atnahs Pharma、 Baudax Bio、 Prestige Brands, Inc.、 Cumberland Pharmaceuticals, Inc.、 Takeda Pharmaceutical Company、 Pfizer Inc.、 McNeil Consumer Healthcare、 Eli Lilly and Company、 Sun Pharmaceutical Industries、 Validus Pharmaceuticals、 Novartis Consumer Health、 Pacira Pharmaceuticals, Inc.、 Almatica Pharma、 Actavis、 Arbor Pharmaceuticals, LLC、 PLx Pharma Inc.、 Heron Therapeutics、 Assertio Therapeutics, Inc.、 Zyla Life Sciences、 Jazz Pharmaceuticals plcなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、非麻酔性鎮痛薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の非麻酔性鎮痛薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の非麻酔性鎮痛薬市場：タイプ別市場シェア、2022年
・サリチル酸塩、アニリン、ピラゾロン、その他有機酸

世界の非麻酔性鎮痛薬市場：用途別、2018年-2023年、2024年-2029年
世界の非麻酔性鎮痛薬市場：用途別市場シェア、2022年
・病院、薬局、専門診療所、その他

世界の非麻酔性鎮痛薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の非麻酔性鎮痛薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における非麻酔性鎮痛薬のグローバル売上、2018年-2023年
・主要企業における非麻酔性鎮痛薬のグローバル売上シェア、2022年
・主要企業における非麻酔性鎮痛薬のグローバル販売量、2018年-2023年
・主要企業における非麻酔性鎮痛薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
GlaxoSmithKline Consumer Healthcare、 Bayer Corporation、 Atnahs Pharma、 Baudax Bio、 Prestige Brands, Inc.、 Cumberland Pharmaceuticals, Inc.、 Takeda Pharmaceutical Company、 Pfizer Inc.、 McNeil Consumer Healthcare、 Eli Lilly and Company、 Sun Pharmaceutical Industries、 Validus Pharmaceuticals、 Novartis Consumer Health、 Pacira Pharmaceuticals, Inc.、 Almatica Pharma、 Actavis、 Arbor Pharmaceuticals, LLC、 PLx Pharma Inc.、 Heron Therapeutics、 Assertio Therapeutics, Inc.、 Zyla Life Sciences、 Jazz Pharmaceuticals plc

*************************************************************

・調査・分析レポートの概要
非麻酔性鎮痛薬市場の定義
市場セグメント
世界の非麻酔性鎮痛薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の非麻酔性鎮痛薬市場規模
世界の非麻酔性鎮痛薬市場規模：2022年 VS 2029年
世界の非麻酔性鎮痛薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの非麻酔性鎮痛薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の非麻酔性鎮痛薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：サリチル酸塩、アニリン、ピラゾロン、その他有機酸
非麻酔性鎮痛薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、薬局、専門診療所、その他
非麻酔性鎮痛薬の用途別グローバル売上・予測

・地域別市場分析
地域別非麻酔性鎮痛薬市場規模 2022年と2029年
地域別非麻酔性鎮痛薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
GlaxoSmithKline Consumer Healthcare、 Bayer Corporation、 Atnahs Pharma、 Baudax Bio、 Prestige Brands, Inc.、 Cumberland Pharmaceuticals, Inc.、 Takeda Pharmaceutical Company、 Pfizer Inc.、 McNeil Consumer Healthcare、 Eli Lilly and Company、 Sun Pharmaceutical Industries、 Validus Pharmaceuticals、 Novartis Consumer Health、 Pacira Pharmaceuticals, Inc.、 Almatica Pharma、 Actavis、 Arbor Pharmaceuticals, LLC、 PLx Pharma Inc.、 Heron Therapeutics、 Assertio Therapeutics, Inc.、 Zyla Life Sciences、 Jazz Pharmaceuticals plc
...

Nonnarcotic analgesics refer to non steroidal anti-inflammatory drugs that have nothing to do with or have little to do with central opioid receptors
This report aims to provide a comprehensive presentation of the global market for Nonnarcotic Analgesics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nonnarcotic Analgesics. This report contains market size and forecasts of Nonnarcotic Analgesics in global, including the following market information:
Global Nonnarcotic Analgesics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Nonnarcotic Analgesics Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Nonnarcotic Analgesics companies in 2022 (%)
The global Nonnarcotic Analgesics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Salicylates Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Nonnarcotic Analgesics include GlaxoSmithKline Consumer Healthcare, Bayer Corporation, Atnahs Pharma, Baudax Bio, Prestige Brands, Inc., Cumberland Pharmaceuticals, Inc., Takeda Pharmaceutical Company, Pfizer Inc. and McNeil Consumer Healthcare, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nonnarcotic Analgesics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nonnarcotic Analgesics Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Nonnarcotic Analgesics Market Segment Percentages, by Type, 2022 (%)
Salicylates
Anilines
Pyrazolones
Other Organic Acids
Global Nonnarcotic Analgesics Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Nonnarcotic Analgesics Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Specialist Clinic
Other
Global Nonnarcotic Analgesics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Nonnarcotic Analgesics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nonnarcotic Analgesics revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Nonnarcotic Analgesics revenues share in global market, 2022 (%)
Key companies Nonnarcotic Analgesics sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Nonnarcotic Analgesics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline Consumer Healthcare
Bayer Corporation
Atnahs Pharma
Baudax Bio
Prestige Brands, Inc.
Cumberland Pharmaceuticals, Inc.
Takeda Pharmaceutical Company
Pfizer Inc.
McNeil Consumer Healthcare
Eli Lilly and Company
Sun Pharmaceutical Industries
Validus Pharmaceuticals
Novartis Consumer Health
Pacira Pharmaceuticals, Inc.
Almatica Pharma
Actavis
Arbor Pharmaceuticals, LLC
PLx Pharma Inc.
Heron Therapeutics
Assertio Therapeutics, Inc.
Zyla Life Sciences
Jazz Pharmaceuticals plc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nonnarcotic Analgesics, market overview.
Chapter 2: Global Nonnarcotic Analgesics market size in revenue and volume.
Chapter 3: Detailed analysis of Nonnarcotic Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nonnarcotic Analgesics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Nonnarcotic Analgesics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Nonnarcotic Analgesics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nonnarcotic Analgesics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nonnarcotic Analgesics Overall Market Size
2.1 Global Nonnarcotic Analgesics Market Size: 2022 VS 2029
2.2 Global Nonnarcotic Analgesics Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Nonnarcotic Analgesics Sales: 2018-2029
3 Company Landscape
3.1 Top Nonnarcotic Analgesics Players in Global Market
3.2 Top Global Nonnarcotic Analgesics Companies Ranked by Revenue
3.3 Global Nonnarcotic Analgesics Revenue by Companies
3.4 Global Nonnarcotic Analgesics Sales by Companies
3.5 Global Nonnarcotic Analgesics Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Nonnarcotic Analgesics Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Nonnarcotic Analgesics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nonnarcotic Analgesics Players in Global Market
3.8.1 List of Global Tier 1 Nonnarcotic Analgesics Companies
3.8.2 List of Global Tier 2 and Tier 3 Nonnarcotic Analgesics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Nonnarcotic Analgesics Market Size Markets, 2022 & 2029
4.1.2 Salicylates
4.1.3 Anilines
4.1.4 Pyrazolones
4.1.5 Other Organic Acids
4.2 By Type – Global Nonnarcotic Analgesics Revenue & Forecasts
4.2.1 By Type – Global Nonnarcotic Analgesics Revenue, 2018-2023
4.2.2 By Type – Global Nonnarcotic Analgesics Revenue, 2024-2029
4.2.3 By Type – Global Nonnarcotic Analgesics Revenue Market Share, 2018-2029
4.3 By Type – Global Nonnarcotic Analgesics Sales & Forecasts
4.3.1 By Type – Global Nonnarcotic Analgesics Sales, 2018-2023
4.3.2 By Type – Global Nonnarcotic Analgesics Sales, 2024-2029
4.3.3 By Type – Global Nonnarcotic Analgesics Sales Market Share, 2018-2029
4.4 By Type – Global Nonnarcotic Analgesics Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Nonnarcotic Analgesics Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.1.4 Specialist Clinic
5.1.5 Other
5.2 By Application – Global Nonnarcotic Analgesics Revenue & Forecasts
5.2.1 By Application – Global Nonnarcotic Analgesics Revenue, 2018-2023
5.2.2 By Application – Global Nonnarcotic Analgesics Revenue, 2024-2029
5.2.3 By Application – Global Nonnarcotic Analgesics Revenue Market Share, 2018-2029
5.3 By Application – Global Nonnarcotic Analgesics Sales & Forecasts
5.3.1 By Application – Global Nonnarcotic Analgesics Sales, 2018-2023
5.3.2 By Application – Global Nonnarcotic Analgesics Sales, 2024-2029
5.3.3 By Application – Global Nonnarcotic Analgesics Sales Market Share, 2018-2029
5.4 By Application – Global Nonnarcotic Analgesics Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Nonnarcotic Analgesics Market Size, 2022 & 2029
6.2 By Region – Global Nonnarcotic Analgesics Revenue & Forecasts
6.2.1 By Region – Global Nonnarcotic Analgesics Revenue, 2018-2023
6.2.2 By Region – Global Nonnarcotic Analgesics Revenue, 2024-2029
6.2.3 By Region – Global Nonnarcotic Analgesics Revenue Market Share, 2018-2029
6.3 By Region – Global Nonnarcotic Analgesics Sales & Forecasts
6.3.1 By Region – Global Nonnarcotic Analgesics Sales, 2018-2023
6.3.2 By Region – Global Nonnarcotic Analgesics Sales, 2024-2029
6.3.3 By Region – Global Nonnarcotic Analgesics Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Nonnarcotic Analgesics Revenue, 2018-2029
6.4.2 By Country – North America Nonnarcotic Analgesics Sales, 2018-2029
6.4.3 US Nonnarcotic Analgesics Market Size, 2018-2029
6.4.4 Canada Nonnarcotic Analgesics Market Size, 2018-2029
6.4.5 Mexico Nonnarcotic Analgesics Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Nonnarcotic Analgesics Revenue, 2018-2029
6.5.2 By Country – Europe Nonnarcotic Analgesics Sales, 2018-2029
6.5.3 Germany Nonnarcotic Analgesics Market Size, 2018-2029
6.5.4 France Nonnarcotic Analgesics Market Size, 2018-2029
6.5.5 U.K. Nonnarcotic Analgesics Market Size, 2018-2029
6.5.6 Italy Nonnarcotic Analgesics Market Size, 2018-2029
6.5.7 Russia Nonnarcotic Analgesics Market Size, 2018-2029
6.5.8 Nordic Countries Nonnarcotic Analgesics Market Size, 2018-2029
6.5.9 Benelux Nonnarcotic Analgesics Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Nonnarcotic Analgesics Revenue, 2018-2029
6.6.2 By Region – Asia Nonnarcotic Analgesics Sales, 2018-2029
6.6.3 China Nonnarcotic Analgesics Market Size, 2018-2029
6.6.4 Japan Nonnarcotic Analgesics Market Size, 2018-2029
6.6.5 South Korea Nonnarcotic Analgesics Market Size, 2018-2029
6.6.6 Southeast Asia Nonnarcotic Analgesics Market Size, 2018-2029
6.6.7 India Nonnarcotic Analgesics Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Nonnarcotic Analgesics Revenue, 2018-2029
6.7.2 By Country – South America Nonnarcotic Analgesics Sales, 2018-2029
6.7.3 Brazil Nonnarcotic Analgesics Market Size, 2018-2029
6.7.4 Argentina Nonnarcotic Analgesics Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Nonnarcotic Analgesics Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Nonnarcotic Analgesics Sales, 2018-2029
6.8.3 Turkey Nonnarcotic Analgesics Market Size, 2018-2029
6.8.4 Israel Nonnarcotic Analgesics Market Size, 2018-2029
6.8.5 Saudi Arabia Nonnarcotic Analgesics Market Size, 2018-2029
6.8.6 UAE Nonnarcotic Analgesics Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline Consumer Healthcare
7.1.1 GlaxoSmithKline Consumer Healthcare Company Summary
7.1.2 GlaxoSmithKline Consumer Healthcare Business Overview
7.1.3 GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Major Product Offerings
7.1.4 GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline Consumer Healthcare Key News & Latest Developments
7.2 Bayer Corporation
7.2.1 Bayer Corporation Company Summary
7.2.2 Bayer Corporation Business Overview
7.2.3 Bayer Corporation Nonnarcotic Analgesics Major Product Offerings
7.2.4 Bayer Corporation Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.2.5 Bayer Corporation Key News & Latest Developments
7.3 Atnahs Pharma
7.3.1 Atnahs Pharma Company Summary
7.3.2 Atnahs Pharma Business Overview
7.3.3 Atnahs Pharma Nonnarcotic Analgesics Major Product Offerings
7.3.4 Atnahs Pharma Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.3.5 Atnahs Pharma Key News & Latest Developments
7.4 Baudax Bio
7.4.1 Baudax Bio Company Summary
7.4.2 Baudax Bio Business Overview
7.4.3 Baudax Bio Nonnarcotic Analgesics Major Product Offerings
7.4.4 Baudax Bio Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.4.5 Baudax Bio Key News & Latest Developments
7.5 Prestige Brands, Inc.
7.5.1 Prestige Brands, Inc. Company Summary
7.5.2 Prestige Brands, Inc. Business Overview
7.5.3 Prestige Brands, Inc. Nonnarcotic Analgesics Major Product Offerings
7.5.4 Prestige Brands, Inc. Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.5.5 Prestige Brands, Inc. Key News & Latest Developments
7.6 Cumberland Pharmaceuticals, Inc.
7.6.1 Cumberland Pharmaceuticals, Inc. Company Summary
7.6.2 Cumberland Pharmaceuticals, Inc. Business Overview
7.6.3 Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Major Product Offerings
7.6.4 Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.6.5 Cumberland Pharmaceuticals, Inc. Key News & Latest Developments
7.7 Takeda Pharmaceutical Company
7.7.1 Takeda Pharmaceutical Company Company Summary
7.7.2 Takeda Pharmaceutical Company Business Overview
7.7.3 Takeda Pharmaceutical Company Nonnarcotic Analgesics Major Product Offerings
7.7.4 Takeda Pharmaceutical Company Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.7.5 Takeda Pharmaceutical Company Key News & Latest Developments
7.8 Pfizer Inc.
7.8.1 Pfizer Inc. Company Summary
7.8.2 Pfizer Inc. Business Overview
7.8.3 Pfizer Inc. Nonnarcotic Analgesics Major Product Offerings
7.8.4 Pfizer Inc. Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.8.5 Pfizer Inc. Key News & Latest Developments
7.9 McNeil Consumer Healthcare
7.9.1 McNeil Consumer Healthcare Company Summary
7.9.2 McNeil Consumer Healthcare Business Overview
7.9.3 McNeil Consumer Healthcare Nonnarcotic Analgesics Major Product Offerings
7.9.4 McNeil Consumer Healthcare Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.9.5 McNeil Consumer Healthcare Key News & Latest Developments
7.10 Eli Lilly and Company
7.10.1 Eli Lilly and Company Company Summary
7.10.2 Eli Lilly and Company Business Overview
7.10.3 Eli Lilly and Company Nonnarcotic Analgesics Major Product Offerings
7.10.4 Eli Lilly and Company Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.10.5 Eli Lilly and Company Key News & Latest Developments
7.11 Sun Pharmaceutical Industries
7.11.1 Sun Pharmaceutical Industries Company Summary
7.11.2 Sun Pharmaceutical Industries Nonnarcotic Analgesics Business Overview
7.11.3 Sun Pharmaceutical Industries Nonnarcotic Analgesics Major Product Offerings
7.11.4 Sun Pharmaceutical Industries Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.11.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.12 Validus Pharmaceuticals
7.12.1 Validus Pharmaceuticals Company Summary
7.12.2 Validus Pharmaceuticals Nonnarcotic Analgesics Business Overview
7.12.3 Validus Pharmaceuticals Nonnarcotic Analgesics Major Product Offerings
7.12.4 Validus Pharmaceuticals Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.12.5 Validus Pharmaceuticals Key News & Latest Developments
7.13 Novartis Consumer Health
7.13.1 Novartis Consumer Health Company Summary
7.13.2 Novartis Consumer Health Nonnarcotic Analgesics Business Overview
7.13.3 Novartis Consumer Health Nonnarcotic Analgesics Major Product Offerings
7.13.4 Novartis Consumer Health Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.13.5 Novartis Consumer Health Key News & Latest Developments
7.14 Pacira Pharmaceuticals, Inc.
7.14.1 Pacira Pharmaceuticals, Inc. Company Summary
7.14.2 Pacira Pharmaceuticals, Inc. Business Overview
7.14.3 Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Major Product Offerings
7.14.4 Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.14.5 Pacira Pharmaceuticals, Inc. Key News & Latest Developments
7.15 Almatica Pharma
7.15.1 Almatica Pharma Company Summary
7.15.2 Almatica Pharma Business Overview
7.15.3 Almatica Pharma Nonnarcotic Analgesics Major Product Offerings
7.15.4 Almatica Pharma Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.15.5 Almatica Pharma Key News & Latest Developments
7.16 Actavis
7.16.1 Actavis Company Summary
7.16.2 Actavis Business Overview
7.16.3 Actavis Nonnarcotic Analgesics Major Product Offerings
7.16.4 Actavis Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.16.5 Actavis Key News & Latest Developments
7.17 Arbor Pharmaceuticals, LLC
7.17.1 Arbor Pharmaceuticals, LLC Company Summary
7.17.2 Arbor Pharmaceuticals, LLC Business Overview
7.17.3 Arbor Pharmaceuticals, LLC Nonnarcotic Analgesics Major Product Offerings
7.17.4 Arbor Pharmaceuticals, LLC Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.17.5 Arbor Pharmaceuticals, LLC Key News & Latest Developments
7.18 PLx Pharma Inc.
7.18.1 PLx Pharma Inc. Company Summary
7.18.2 PLx Pharma Inc. Business Overview
7.18.3 PLx Pharma Inc. Nonnarcotic Analgesics Major Product Offerings
7.18.4 PLx Pharma Inc. Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.18.5 PLx Pharma Inc. Key News & Latest Developments
7.19 Heron Therapeutics
7.19.1 Heron Therapeutics Company Summary
7.19.2 Heron Therapeutics Business Overview
7.19.3 Heron Therapeutics Nonnarcotic Analgesics Major Product Offerings
7.19.4 Heron Therapeutics Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.19.5 Heron Therapeutics Key News & Latest Developments
7.20 Assertio Therapeutics, Inc.
7.20.1 Assertio Therapeutics, Inc. Company Summary
7.20.2 Assertio Therapeutics, Inc. Business Overview
7.20.3 Assertio Therapeutics, Inc. Nonnarcotic Analgesics Major Product Offerings
7.20.4 Assertio Therapeutics, Inc. Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.20.5 Assertio Therapeutics, Inc. Key News & Latest Developments
7.21 Zyla Life Sciences
7.21.1 Zyla Life Sciences Company Summary
7.21.2 Zyla Life Sciences Business Overview
7.21.3 Zyla Life Sciences Nonnarcotic Analgesics Major Product Offerings
7.21.4 Zyla Life Sciences Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.21.5 Zyla Life Sciences Key News & Latest Developments
7.22 Jazz Pharmaceuticals plc
7.22.1 Jazz Pharmaceuticals plc Company Summary
7.22.2 Jazz Pharmaceuticals plc Business Overview
7.22.3 Jazz Pharmaceuticals plc Nonnarcotic Analgesics Major Product Offerings
7.22.4 Jazz Pharmaceuticals plc Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.22.5 Jazz Pharmaceuticals plc Key News & Latest Developments
8 Global Nonnarcotic Analgesics Production Capacity, Analysis
8.1 Global Nonnarcotic Analgesics Production Capacity, 2018-2029
8.2 Nonnarcotic Analgesics Production Capacity of Key Manufacturers in Global Market
8.3 Global Nonnarcotic Analgesics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Nonnarcotic Analgesics Supply Chain Analysis
10.1 Nonnarcotic Analgesics Industry Value Chain
10.2 Nonnarcotic Analgesics Upstream Market
10.3 Nonnarcotic Analgesics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nonnarcotic Analgesics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 非ステロイド性抗炎症薬（NSAID）のグローバル市場展望 2023年-2029年：サリチル酸塩、プロピオン酸誘導体、酢酸誘導体、エノール酸（オキシカム）誘導体、アントラニル酸誘導体（フェナム酸）、選択的COX-2阻害剤（コキシブ）、サルファ薬
  • 鎮痛剤のグローバル市場展望 2023年-2029年：非ステロイド性抗炎症薬、中枢性鎮痛薬
  • 2,6-ジクロロ-4-（トリフルオロメチル）アニリン（dctfma）の世界市場2024：メーカー別、地域別、タイプ・用途別
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23JU5812 )"非麻酔性鎮痛薬のグローバル市場展望 2023年-2029年：サリチル酸塩、アニリン、ピラゾロン、その他有機酸" (英文：Nonnarcotic Analgesics Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。